{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T00:29:40Z","timestamp":1771460980610,"version":"3.50.1"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,7,14]]},"DOI":"10.7759\/cureus.41878","type":"journal-article","created":{"date-parts":[[2023,7,14]],"date-time":"2023-07-14T15:31:06Z","timestamp":1689348666000},"source":"Crossref","is-referenced-by-count":2,"title":["Intravenous Thrombolysis for Central Retinal Artery Occlusion: A Look at the Literature for the Emergency Medicine Physician"],"prefix":"10.7759","author":[{"given":"Zachary","family":"Webb","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1007\/s00417-020-04642-7","article-title":"Albrecht von Graefe in the present, the past, and the future","volume":"258","author":"Rohrbach JM","year":"2020","unstructured":"Rohrbach JM. Albrecht von Graefe in the present, the past, and the future. Graefes Arch Clin Exp Ophthalmol. 2020, 258:1141-7. 10.1007\/s00417-020-04642-7","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajo.2011.05.005","article-title":"The incidence of central retinal artery occlusion in Olmsted County, Minnesota","volume":"152","author":"Leavitt JA","year":"2011","unstructured":"Leavitt JA, Larson TA, Hodge DO, Gullerud RE. The incidence of central retinal artery occlusion in Olmsted County, Minnesota. Am J Ophthalmol. 2011, 152:820-3.e2. 10.1016\/j.ajo.2011.05.005","journal-title":"Am J Ophthalmol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/j.oret.2021.10.011","article-title":"Emergency department presentation of retinal artery occlusion","volume":"6","author":"Yousuf SJ","year":"2022","unstructured":"Yousuf SJ, Guiseppi R, Katz DM, Nnorom SO, Akinyemi OA. Emergency department presentation of retinal artery occlusion. Ophthalmol Retina. 2022, 6:318-24. 10.1016\/j.oret.2021.10.011","journal-title":"Ophthalmol Retina"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/j.ncl.2021.01.004","article-title":"Neuro-ophthalmic emergencies","volume":"39","author":"Spiegel SJ","year":"2021","unstructured":"Spiegel SJ, Moss HE. Neuro-ophthalmic emergencies. Neurol Clin. 2021, 39:631-47. 10.1016\/j.ncl.2021.01.004","journal-title":"Neurol Clin"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1161\/STR.0000000000000366","article-title":"Management of central retinal artery occlusion: a scientific statement from the American Heart Association","volume":"52","author":"Mac Grory B","year":"2021","unstructured":"Mac Grory B, Schrag M, Biousse V, et al.. Management of central retinal artery occlusion: a scientific statement from the American Heart Association. Stroke. 2021, 52:e282-94. 10.1161\/STR.0000000000000366","journal-title":"Stroke"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/j.jstrokecerebrovasdis.2021.105828","article-title":"Structural and functional imaging of the retina in central retinal artery occlusion - current approaches and future directions","volume":"30","author":"Mac Grory B","year":"2021","unstructured":"Mac Grory B, Schrag M, Poli S, et al.. Structural and functional imaging of the retina in central retinal artery occlusion - current approaches and future directions. J Stroke Cerebrovasc Dis. 2021, 30:105828. 10.1016\/j.jstrokecerebrovasdis.2021.105828","journal-title":"J Stroke Cerebrovasc Dis"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(20)31559-2","article-title":"Retinal vascular occlusions","volume":"396","author":"Scott IU","year":"2020","unstructured":"Scott IU, Campochiaro PA, Newman NJ, Biousse V. Retinal vascular occlusions. Lancet. 2020, 396:1927-40. 10.1016\/S0140-6736(20)31559-2","journal-title":"Lancet"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.4103\/ijo.IJO_1446_18","article-title":"Central retinal artery occlusion","volume":"66","author":"Hayreh SS","year":"2018","unstructured":"Hayreh SS. Central retinal artery occlusion. Indian J Ophthalmol. 2018, 66:1684-94. 10.4103\/ijo.IJO_1446_18","journal-title":"Indian J Ophthalmol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2009.03.006","article-title":"Retinal artery occlusion: associated systemic and ophthalmic abnormalities","volume":"116","author":"Hayreh SS","year":"2009","unstructured":"Hayreh SS, Podhajsky PA, Zimmerman MB. Retinal artery occlusion: associated systemic and ophthalmic abnormalities. Ophthalmology. 2009, 116:1928-36. 10.1016\/j.ophtha.2009.03.006","journal-title":"Ophthalmology"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjcard.2022.07.040","article-title":"Outcomes and readmission in patients with retinal artery occlusion (from the nationwide readmission database)","volume":"183","author":"Suri K","year":"2022","unstructured":"Suri K, Majmundar M, Kumar A, Patel KN, Zhou XY, Zala H, Kalra A. Outcomes and readmission in patients with retinal artery occlusion (from the nationwide readmission database). Am J Cardiol. 2022, 183:105-8. 10.1016\/j.amjcard.2022.07.040","journal-title":"Am J Cardiol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD001989.pub3","article-title":"Interventions for acute non-arteritic central retinal artery occlusion","volume":"1","author":"Lin JC","year":"2023","unstructured":"Lin JC, Song S, Ng SM, Scott IU, Greenberg PB. Interventions for acute non-arteritic central retinal artery occlusion. Cochrane Database Syst Rev. 2023, 1:CD001989. 10.1002\/14651858.CD001989.pub3","journal-title":"Cochrane Database Syst Rev"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1161\/STROKEAHA.119.027034","article-title":"Characteristics and outcomes of retinal artery occlusion: nationally representative data","volume":"51","author":"Schorr EM","year":"2020","unstructured":"Schorr EM, Rossi KC, Stein LK, Park BL, Tuhrim S, Dhamoon MS. Characteristics and outcomes of retinal artery occlusion: nationally representative data. Stroke. 2020, 51:800-7. 10.1161\/STROKEAHA.119.027034","journal-title":"Stroke"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1016\/j.jstrokecerebrovasdis.2021.105970","article-title":"Controversies on the recommended treatment for central retinal artery occlusion","volume":"30","author":"Tuuminen R","year":"2021","unstructured":"Tuuminen R, Achiron A, Kanclerz P. Controversies on the recommended treatment for central retinal artery occlusion. J Stroke Cerebrovasc Dis. 2021, 30:105970. 10.1016\/j.jstrokecerebrovasdis.2021.105970","journal-title":"J Stroke Cerebrovasc Dis"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1007\/s12264-020-00534-2","article-title":"Guidelines for acute ischemic stroke treatment","volume":"36","author":"Qiu S","year":"2020","unstructured":"Qiu S, Xu Y. Guidelines for acute ischemic stroke treatment. Neurosci Bull. 2020, 36:1229-32. 10.1007\/s12264-020-00534-2","journal-title":"Neurosci Bull"},{"key":"ref15","article-title":"Intravenous recombinant tissue-type plasminogen activator thrombolysis in treatment of central retinal artery occlusion","volume":"120","author":"Kattah JC","year":"2002","unstructured":"Kattah JC, Wang DZ, Reddy C. Intravenous recombinant tissue-type plasminogen activator thrombolysis in treatment of central retinal artery occlusion. Arch Ophthalmol (Chic, Ill : 1960). 2002, 120:1234-6.","journal-title":"Arch Ophthalmol (Chic, Ill : 1960)"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1161\/STROKEAHA.119.027478","article-title":"Thrombolytic therapy for acute central retinal artery occlusion","volume":"51","author":"Mac Grory B","year":"2020","unstructured":"Mac Grory B, Lavin P, Kirshner H, Schrag M. Thrombolytic therapy for acute central retinal artery occlusion. Stroke. 2020, 51:687-95. 10.1161\/STROKEAHA.119.027478","journal-title":"Stroke"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1161\/STROKEAHA.115.009839","article-title":"Retrobulbar spot sign predicts thrombolytic treatment effects and etiology in central retinal artery occlusion","volume":"46","author":"Nedelmann M","year":"2015","unstructured":"Nedelmann M, Graef M, Weinand F, Wassill KH, Kaps M, Lorenz B, Tanislav C. Retrobulbar spot sign predicts thrombolytic treatment effects and etiology in central retinal artery occlusion. Stroke. 2015, 46:2322-4. 10.1161\/STROKEAHA.115.009839","journal-title":"Stroke"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1177\/1747493016687578","article-title":"Management of acute central retinal artery occlusion: Intravenous thrombolysis is feasible and safe","volume":"12","author":"Pr\u00e9terre C","year":"2017","unstructured":"Pr\u00e9terre C, Godeneche G, Vandamme X, et al.. Management of acute central retinal artery occlusion: Intravenous thrombolysis is feasible and safe. Int J Stroke. 2017, 12:720-3. 10.1177\/1747493016687578","journal-title":"Int J Stroke"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0198114","article-title":"Intravenous thrombolysis in acute central retinal artery occlusion - a prospective interventional case series","volume":"13","author":"Schultheiss M","year":"2018","unstructured":"Schultheiss M, H\u00e4rtig F, Spitzer MS, et al.. Intravenous thrombolysis in acute central retinal artery occlusion - a prospective interventional case series. PLoS One. 2018, 13:e0198114. 10.1371\/journal.pone.0198114","journal-title":"PLoS One"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1001\/jamaneurol.2015.1578","article-title":"Intravenous fibrinolytic therapy in central retinal artery occlusion: a patient-level meta-analysis","volume":"72","author":"Schrag M","year":"2015","unstructured":"Schrag M, Youn T, Schindler J, Kirshner H, Greer D. Intravenous fibrinolytic therapy in central retinal artery occlusion: a patient-level meta-analysis. JAMA Neurol. 2015, 72:1148-54. 10.1001\/jamaneurol.2015.1578","journal-title":"JAMA Neurol"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1161\/strokeaha.119.028743","article-title":"Intravenous Fibrinolysis for Central Retinal Artery Occlusion","volume":"51","author":"Mac Grory B","year":"2020","unstructured":"Mac Grory B, Nackenoff A, Poli S, et al.. Intravenous Fibrinolysis for Central Retinal Artery Occlusion. Stroke. 2020, 51:2018-25. 10.1161\/strokeaha.119.028743","journal-title":"Stroke"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1097\/WNO.0000000000001027","article-title":"Thrombolysis for central retinal artery occlusion in 2020: time is vision!","volume":"40","author":"Dumitrascu OM","year":"2020","unstructured":"Dumitrascu OM, Newman NJ, Biousse V. Thrombolysis for central retinal artery occlusion in 2020: time is vision!. J Neuroophthalmol. 2020, 40:333-45. 10.1097\/WNO.0000000000001027","journal-title":"J Neuroophthalmol"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1001\/archopht.1995.01100090016007","article-title":"Peripheral thrombolytic therapy for central retinal artery occlusion","volume":"113","author":"Mames RN","year":"1995","unstructured":"Mames RN, Shugar JK, Levy N, Brasington A, Margo CE. Peripheral thrombolytic therapy for central retinal artery occlusion. Arch Ophthalmol. 1995, 113:1094. 10.1001\/archopht.1995.01100090016007","journal-title":"Arch Ophthalmol"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajo.2008.06.016","article-title":"Intravenous thrombolysis with low-dose recombinant tissue plasminogen activator in central retinal artery occlusion","volume":"146","author":"Hattenbach LO","year":"2008","unstructured":"Hattenbach LO, Kuhli-Hattenbach C, Scharrer I, Baatz H. Intravenous thrombolysis with low-dose recombinant tissue plasminogen activator in central retinal artery occlusion. Am J Ophthalmol. 2008, 146:700-6. 10.1016\/j.ajo.2008.06.016","journal-title":"Am J Ophthalmol"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1097\/SCS.0000000000007134","article-title":"Intravenous recombinant tissue-type plasminogen activator thrombolysis for acute central retinal artery occlusion","volume":"32","author":"Wang X","year":"2021","unstructured":"Wang X, Liu Y, Suo Y, et al.. Intravenous recombinant tissue-type plasminogen activator thrombolysis for acute central retinal artery occlusion. J Craniofac Surg. 2021, 32:313-6. 10.1097\/SCS.0000000000007134","journal-title":"J Craniofac Surg"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.3892\/etm.2016.3681","article-title":"Observation on therapeutic efficacy of rt-PA intravenous thrombolysis combined with compound anisodine injection on central retinal artery occlusion","volume":"12","author":"Wu XJ","year":"2016","unstructured":"Wu XJ, Gao F, Liu X, Zhao Q. Observation on therapeutic efficacy of rt-PA intravenous thrombolysis combined with compound anisodine injection on central retinal artery occlusion. Exp Ther Med. 2016, 12:2617-21. 10.3892\/etm.2016.3681","journal-title":"Exp Ther Med"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.3390\/life12081279","article-title":"Retinal infarction: A pilot study on the efficacy and safety of intravenous thrombolysis and underlying aetiologies","volume":"12","author":"Sch\u00f6necker S","year":"2022","unstructured":"Sch\u00f6necker S, Wischmann J, Thunstedt DC, Feil K, Mackert MJ, Priglinger S, Kellert L. Retinal infarction: A pilot study on the efficacy and safety of intravenous thrombolysis and underlying aetiologies. Life (Basel). 2022, 12:10.3390\/life12081279","journal-title":"Life (Basel)"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1007\/s00415-022-11439-7","article-title":"Thrombolysis in central retinal artery occlusion: a retrospective observational study","volume":"270","author":"Raber FP","year":"2023","unstructured":"Raber FP, Gmeiner FV, Dreyhaupt J, et al.. Thrombolysis in central retinal artery occlusion: a retrospective observational study. J Neurol. 2023, 270:891-7. 10.1007\/s00415-022-11439-7","journal-title":"J Neurol"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.27840","article-title":"Central retinal artery occlusion: can we effectively manage this ocular emergency in a hospital setting?","volume":"14","author":"Jayasinghe M","year":"2022","unstructured":"Jayasinghe M, Prathiraja O, Kayani AM, Jena R, Singhal M, Silva MS. Central retinal artery occlusion: can we effectively manage this ocular emergency in a hospital setting?. Cureus. 2022, 14:e27840. 10.7759\/cureus.27840","journal-title":"Cureus"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.4103\/2211-5056.353126","article-title":"A review of the management of central retinal artery occlusion","volume":"12","author":"Madike R","year":"2022","unstructured":"Madike R, Cugati S, Chen C. A review of the management of central retinal artery occlusion. Taiwan J Ophthalmol. 2022, 12:273-81. 10.4103\/2211-5056.353126","journal-title":"Taiwan J Ophthalmol"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.31348\/2021\/32","article-title":"Intravenous thrombolytic therapy for acute nonarteritic central retinal artery occlusion. A review","volume":"78","author":"Jansk\u00e1 K","year":"2022","unstructured":"Jansk\u00e1 K, Bodn\u00e1r R, Jansk\u00fd P, Vosko M. Intravenous thrombolytic therapy for acute nonarteritic central retinal artery occlusion. A review. Cesk Slov Oftalmol. 2022, 78:101-9. 10.31348\/2021\/32","journal-title":"Cesk Slov Oftalmol"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.2147\/OPTH.S403433","article-title":"Neuroprotection for nonarteritic central retinal artery occlusion: lessons from acute ischemic stroke","volume":"17","author":"Okonkwo ON","year":"2023","unstructured":"Okonkwo ON, Agweye CT, Akanbi T. Neuroprotection for nonarteritic central retinal artery occlusion: lessons from acute ischemic stroke. Clin Ophthalmol. 2023, 17:1531-43. 10.2147\/OPTH.S403433","journal-title":"Clin Ophthalmol"},{"key":"ref33","unstructured":"A Phase III Randomized, Blind, Double Dummy, Multicenter Study Assessing the Efficacy and Safety of IV THrombolysis (Alteplase) in Patients With acutE Central retInal Artery Occlusion - Full Text View - ClinicalTrials.gov. (2023). Accessed. June 30, 2023: https:\/\/classic.clinicaltrials.gov\/ct2\/show\/NCT03197194.."},{"key":"ref34","unstructured":"Early Reperfusion Therapy With Intravenous Alteplase for Recovery of VISION in Acute Central Retinal Artery Occlusion - Full Text View - ClinicalTrials.gov. (2023). Accessed. June 30, 2023: https:\/\/classic.clinicaltrials.gov\/ct2\/show\/NCT04965038."},{"key":"ref35","unstructured":"TENecteplase in Central Retinal Artery Occlusion Stuy (TenCRAOS) - Full Text View - ClinicalTrials.gov. Accessed. June 30, 2023. https:\/\/classic.clinicaltrials.gov\/ct2\/show\/NCT04526951.."},{"key":"ref36","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2019.09.028","article-title":"Retinal and ophthalmic artery occlusions preferred practice pattern\u00ae","volume":"127","author":"Flaxel CJ","year":"2020","unstructured":"Flaxel CJ, Adelman RA, Bailey ST, Fawzi A, Lim JI, Vemulakonda GA, Ying GS. Retinal and ophthalmic artery occlusions preferred practice pattern\u00ae. Ophthalmology. 2020, 127:P259-87. 10.1016\/j.ophtha.2019.09.028","journal-title":"Ophthalmology"},{"key":"ref37","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2020.04.022","article-title":"Re: Flaxel et\u00a0al.: Retinal and ophthalmic artery occlusions Preferred Practice Pattern\u00ae (Ophthalmology. 2020;127:P259-P287)","volume":"127","author":"Mac Grory B","year":"2020","unstructured":"Mac Grory B, Schrag M. Re: Flaxel et\u00a0al.: Retinal and ophthalmic artery occlusions Preferred Practice Pattern\u00ae (Ophthalmology. 2020;127:P259-P287). Ophthalmology. 2020, 127:e59-60. 10.1016\/j.ophtha.2020.04.022","journal-title":"Ophthalmology"},{"key":"ref38","doi-asserted-by":"publisher","DOI":"10.1089\/tmj.2022.0286","article-title":"Telemedicine for acute monocular visual loss: a retrospective large TeleStroke network experience","author":"Dumitrascu OM","year":"2023","unstructured":"Dumitrascu OM, English S, Alhayek N, et al.. Telemedicine for acute monocular visual loss: a retrospective large TeleStroke network experience. Telemed J E Health. 2023, 10.1089\/tmj.2022.0286","journal-title":"Telemed J E Health"},{"key":"ref39","doi-asserted-by":"publisher","DOI":"10.1038\/s41433-020-0889-x","article-title":"Training in and comfort with diagnosis and management of ophthalmic emergencies among emergency medicine physicians in the United States","volume":"34","author":"Uhr JH","year":"2020","unstructured":"Uhr JH, Governatori NJ, Zhang QE, et al.. Training in and comfort with diagnosis and management of ophthalmic emergencies among emergency medicine physicians in the United States. Eye (Lond). 2020, 34:1504-11. 10.1038\/s41433-020-0889-x","journal-title":"Eye (Lond)"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/169822-intravenous-thrombolysis-for-central-retinal-artery-occlusion-a-look-at-the-literature-for-the-emergency-medicine-physician","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T20:05:55Z","timestamp":1707509155000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/169822-intravenous-thrombolysis-for-central-retinal-artery-occlusion-a-look-at-the-literature-for-the-emergency-medicine-physician"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7,14]]},"references-count":39,"URL":"https:\/\/doi.org\/10.7759\/cureus.41878","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2023,7,14]]}}}